15,000 second chances: Bone Marrow Transplant program celebrates new milestone

April 24, 2019 | Michael Easterling and Samantha Bonar

City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient, a remarkable milestone considering that the initiative started with just two physicians, three beds and guarded expectations in 1976.

Continue Reading

City of Hope to participate in NCI-MATCH clinical trial

April 5, 2019 | City of Hope

City of Hope’s Clinical Molecular Diagnostic Laboratory (CMDL) is participating as a CLIA-Certified/Accredited laboratory in the NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131) precision medicine trial.

What home DNA kits can (and can't) tell you about cancer risk

February 6, 2019 | Abe Rosenberg

If you've thought about trying one of those home DNA kits, think before you spit. Even the most elaborate home test only scratches the surface.

Big data for better results: the power and the promise of precision medicine

September 26, 2018 | Sam Lazaryev

Jeff Trent, Ph.D., TGen president and research director, discusses the promise of precision medicine and his company’s exciting initiative with City of Hope.

Researcher's Ovarian Cancer Discovery Takes on Special Meaning

June 27, 2018 | City of Hope

The results of a study published earlier this year by TGen researchers (City of Hope affiliate) in the journal Clinical Cancer Research suggest an existing leukemia drug, ponatinib, shows promise against SCCOHT.

Cancer Urban Legend: Cancer Runs in My Family, I Can’t Reduce My Risk

February 13, 2018 | Abe Rosenberg

As knowledge of cancer's genetic nature expands, so do the treatment options. Learn more from Thomas Slavin, M.D., clinical geneticist at City of Hope.

City of Hope's CAR T Work Gets a Boost from TGen

January 30, 2018 | City of Hope

As an affiliate of City of Hope, TGen will use its genomics expertise to chart a path to greater precision in CAR T therapies for cancer patients.

Really Big Data: How Genomics Is Poised to Reshape Cancer Care

November 9, 2017 | Abe Rosenberg

The exploding field of cancer genomics is enabling that kind of prediction for a growing number of inherited cancers, like identifying one of the many genes beyond BRCA1 and BRCA2 gene mutations linked to breast cancer.

TGen Spotlight: New Study Tackles Sports-Related Concussions

October 16, 2017 | City of Hope

TGen-Riddell partnership results could help future studies lead to advanced methods of injury and disease detection

City of Hope collaborates with The Jackson Laboratory to help speed research discoveries into cures

July 11, 2017 | Denise Heady

A collaboration with The Jackson Laboratory expands access to leading-edge research capabilities to find new treatments for life-threatening diseases.